Physician profile
Jennifer E Simpson
NPI 1700387537
$557.65
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.82 · 2022: $232 · 2023: $216 · 2024: $15.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $232.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rochester Medical Corporation | $167.33 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $86.40 | 2022 | |
| Pfizer INC. | $71.35 | 2023 | |
| Novo Nordisk INC | $50.00 | 2022 | |
| Exact Sciences Corporation | $40.33 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $38.99 | 2023-2024 | Prolia, Evenity, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $23.91 | 2023 | Xifaxan |
| Abbott Laboratories | $23.33 | 2023 | Freestyle Libre 3 |
| Abbvie INC. | $21.85 | 2022 | |
| Eagle Pharmaceuticals, INC. | $18.46 | 2023 | |
| Otsuka America Pharmaceutical, INC. | $15.70 | 2023 | Rexulti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.